Parkinson's DiseaseOTiPNCT01336127
Effectiveness Study of Occupational Therapy in Parkinson's Disease
A study testing Occupational Therapy in people with Parkinson's Disease, run by Radboud University Medical Center at 10 sites in Netherlands.
Trial summary
The purpose of this study is to determine the effectiveness of occupational therapy in Parkinson's disease. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Parkinson's Disease
- What is being tested?
- Occupational Therapy
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 191 participants
- Where
- 10 sitesNetherlands
- Study dates
- Apr 2011to Jun 2013
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Idiopathic Parkinson's Disease
- Indication for referral to occupational therapy
- Home dwelling
- Available for informal support minimal two times a week to a patient who participates in the study
- Available to take part in the intervention
Who cannot join
- Not capable of completing the self assessment forms (i.e. due to language problems or severe cognitive problems_MMSE score < 24).
- Co morbidity with symptoms that interfere with actively taking part in the intervention (e.g psychosis, severe heart condition). Or limitations in activities are dominated by the co morbid condition rather than by Parkinson's Disease.
- Current participation in other allied health research (i.e. PARKFIT)
- Having received occupational therapy intervention in the last 3 months
Trial locations and contacts
10 sites in 1 country.
10 sites in 1 country
Netherlands10 sites
Meander Medisch Centrum
Amersfoort
Gelre Ziekenhuizen
Apeldoorn
Tergooiziekenhuizen
Blaricum
Deventer Ziekenhuis
Deventer
St Jansdal
Harderwijk
Tergooiziekenhuizen
Hilversum
St. Antonius
Utrecht
Diakonessenhuis
Zeist
Gelre Ziekenhuizen
Zutphen
Isala Klinieken
Zwolle
About this study
Official title: Effectiveness of Occupational Therapy in Parkinson's Disease: a Randomized Controlled Trial
The purpose of this study is to determine the effectiveness of occupational therapy in Parkinson's disease.
Read the detailed description
Parkinson's disease is a complex disabling condition progressively affecting activities and participation of patients. Occupational Therapy aims to optimise functional performance and engagement in meaningful roles and activities. The lack of scientific evidence for the effectiveness of Occupational Therapy (OT) in Parkinson's Disease (PD) highlights the urgent need for high quality intervention studies. The Dutch clinical practice guideline for OT in PD (2008)offers a good basis for conducting an intervention study. The completed OTiP pilot underscored the feasibility and the need for a large scale trial.
The OTiP study evaluates the effectiveness of OT in improving daily functioning of patients with PD.
- Conditions
- Parkinson's Disease
- Being tested
- Occupational Therapy
- Keywords
- Occupational Therapy, Parkinson's Disease, Effectiveness, RCT, Activities of daily living, Participation, Caregiver's Burden, Economic evaluation
- Medical subject headings
- Parkinson Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Occupational TherapyBehavioural
Patients in the experimental group will receive 10 weeks (maximum 16 hours) occupational therapy according to a treatment protocol, which is based on the Dutch evidence based guideline for occupational therapy in Parkinson's Disease and refined for this study.
| Study group | Role | What they receive |
|---|---|---|
| occupational therapy | Experimental | 10 weeks occupational therapy according to a protocol (OTiP protocol) based on the Dutch guidelines of occupational therapy in Parkinson's disease Receives: Behavioral: Occupational Therapy |
| No occupational therapy | No intervention | Patients and their caregivers in the control group will have no occupational therapy intervention until their last measurement has taken place (6 months). |
What is being measured
The primary outcome is the main question the study is designed to answer.
Canadian Occupational Performance Measure (COPM)
Perceived activity performance. Three months will be the primary analysis. Effects at follow up will be measured at 6 months (see secondary outcome measures)
Measured: 3 months
Secondary outcomes (24)
Perceive Recall Plan Perform Measure (PRPP)
Observational measure. Activity performance patient
Measured: 3 months
Zarit Burden Inventory (ZBI)
Perceived caregiver burden.(caregiver)
Measured: 3 months
Parkinson's Disease Questionnaire 39 (PDQ-39)
Health related Quality of life (Parkinson specific; patient)
Measured: 3 months
Resource utilization questionnaire
For evaluating costs. (patient and caregiver)
Measured: 3 months
Objective Caregiving Burden
Evaluating hours of care (costs). (caregiver)
Measured: 3 months
Activity Card Sort (ACS)
Participation measure:% retained activities.(patient)
Measured: 3 months
The Utrecht Scale for evaluation of Rehabilitation Participation (USER-P)(section III)
Satisfaction with participation (patient)
Measured: 3 months
Becks depression Inventory (BDI)
Mood and Depression. (patient)
Measured: 3 months
Hospital Anxiety and Depression Scale (HADS)
Mood and depression. (caregiver).
Measured: 3 months
The Utrecht Proactive Coping Competence list (UPCC)
Proactive coping skills. (patient and caregiver)
Measured: 3 months
Fatigue Severity Scale (FSS)
Impact of fatigue (patient)
Measured: 3 months
Canadian Occupational Performance Measure (COPM-satisfaction)
Perceived satisfaction with performance. (patient)
Measured: 3 months
Quality of life-overall
One question on rating overall quality of life (VAS scale). (patient and caregiver).
Measured: 3 months
Zarit Burden Inventory (ZBI)
Perceived caregiver burden. (caregiver)
Measured: 6 months
Parkinson's Disease Questionnaire 39 (PDQ-39)
Health related Quality of life (Parkinson specific)
Measured: 6 months
Objective Caregiving Burden
Evaluating hours of care (costs). (caregiver).
Measured: 6 months
Euroqol EQ-5D
Quality of life. Used for patient and caregiver in evaluation of cost effectiveness
Measured: 6 months
Canadian Occupational Performance Measure (COPM)
Perceived performance in activities. Is primary outcome measure at 3 months, but data of 6 months (follow up) wil be used in a secondary analysis and analysis of cost effectiveness.
Measured: 6 months
Canadian Occupational Performance Measure (COPM-satisfaction)
Perceived satisfaction with performance. (patient)
Measured: 6 months
The Utrecht Scale for evaluation of Rehabilitation Participation (USER-P)(section III)
Satisfaction with participation (patient)
Measured: 6 months
Becks depression Inventory (BDI)
Mood and Depression. (patient)
Measured: 6 months
Hospital Anxiety and Depression Scale (HADS)
Mood and depression. (caregiver).
Measured: 6 months
The Utrecht Proactive Coping Competence list (UPCC)
Proactive coping skills. (patient and caregiver)
Measured: 6 months
Fatigue Severity Scale (FSS)
Impact of fatigue (patient)
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Apr 2011 (estimated)
- Study startApr 2011
- Primary completionFeb 2013
- Study completionJun 2013
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Parkinson's DiseaseStudies of the same condition, open and under way.
- More trials run by Radboud University Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 191 participants (actual)
Sponsor and investigators
- Lead sponsor
- Radboud University Medical Center
- Sponsor type
- University, hospital or other
- Collaborators
- Princess Beatrix Muscle Foundation
- Responsible party
- Sponsor
- Investigators
- Marten Munneke, Phd, Principal investigator, Radboud University Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01336127
- Sponsor's protocol ID
- W.OR09-29
- Acronym
- OTiP
- Status last verified
- Aug 2014
- First submitted
- 17 Mar 2011
- Last updated
- 27 Aug 2014
- Results posted
- No
- Data monitoring committee
- No
Publications
Sturkenboom IH, Hendriks JC, Graff MJ, Adang EM, Munneke M, Nijhuis-van der Sanden MW, Bloem BR. Economic evaluation of occupational therapy in Parkinson's disease: A randomized controlled trial. Mov Disord. 2015 Jul;30(8):1059-67. doi: 10.1002/mds.26217. Epub 2015 Apr 8.
PubMed 25854809Sturkenboom IH, Graff MJ, Hendriks JC, Veenhuizen Y, Munneke M, Bloem BR, Nijhuis-van der Sanden MW; OTiP study group. Efficacy of occupational therapy for patients with Parkinson's disease: a randomised controlled trial. Lancet Neurol. 2014 Jun;13(6):557-66. doi: 10.1016/S1474-4422(14)70055-9. Epub 2014 Apr 8.
PubMed 24726066Sturkenboom IH, Graff MJ, Borm GF, Adang EM, Nijhuis-van der Sanden MW, Bloem BR, Munneke M. Effectiveness of occupational therapy in Parkinson's disease: study protocol for a randomized controlled trial. Trials. 2013 Feb 2;14:34. doi: 10.1186/1745-6215-14-34.
PubMed 23374761
Study at a glance
From the registry record, last updated by the sponsor on 27 Aug 2014. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of Occupational Therapy in Parkinson's Disease: a Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT01336127
- Acronym / sponsor ID
- OTiP / W.OR09-29
- Conditions
- Parkinson's Disease
- Keywords
- Occupational Therapy, Parkinson's Disease, Effectiveness, RCT, Activities of daily living, Participation, Caregiver's Burden, Economic evaluation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 191 participants (actual)
- Lead sponsor
- Radboud University Medical CenterUniversity, hospital or other
- Collaborators
- Princess Beatrix Muscle Foundation
- Study start
- Apr 2011
- Primary completion
- Feb 2013 (actual)
- Study completion
- Jun 2013 (actual)
- First posted
- 15 Apr 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to determine the effectiveness of occupational therapy in Parkinson's disease.
Detailed description
Parkinson's disease is a complex disabling condition progressively affecting activities and participation of patients. Occupational Therapy aims to optimise functional performance and engagement in meaningful roles and activities. The lack of scientific evidence for the effectiveness of Occupational Therapy (OT) in Parkinson's Disease (PD) highlights the urgent need for high quality intervention studies. The Dutch clinical practice guideline for OT in PD (2008)offers a good basis for conducting an intervention study. The completed OTiP pilot underscored the feasibility and the need for a large scale trial.
The OTiP study evaluates the effectiveness of OT in improving daily functioning of patients with PD.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| occupational therapy | Experimental | Behavioral: Occupational Therapy10 weeks occupational therapy according to a protocol (OTiP protocol) based on the Dutch guidelines of occupational therapy in Parkinson's disease |
| No occupational therapy | No intervention | –Patients and their caregivers in the control group will have no occupational therapy intervention until their last measurement has taken place (6 months). |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Idiopathic Parkinson's Disease
- Indication for referral to occupational therapy
- Home dwelling
- Available for informal support minimal two times a week to a patient who participates in the study
- Available to take part in the intervention
Key exclusion criteria (4 listed)
- Not capable of completing the self assessment forms (i.e. due to language problems or severe cognitive problems_MMSE score < 24).
- Co morbidity with symptoms that interfere with actively taking part in the intervention (e.g psychosis, severe heart condition). Or limitations in activities are dominated by the co morbid condition rather than by Parkinson's Disease.
- Current participation in other allied health research (i.e. PARKFIT)
- Having received occupational therapy intervention in the last 3 months
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Occupational TherapyPatients in the experimental group will receive 10 weeks (maximum 16 hours) occupational therapy according to a treatment protocol, which is based on the Dutch evidence based guideline for occupational therapy in Parkinson's Disease and refined for this study. | Behavioural | occupational therapy |
Primary outcome
Canadian Occupational Performance Measure (COPM)
Time frame: 3 months
Perceived activity performance. Three months will be the primary analysis. Effects at follow up will be measured at 6 months (see secondary outcome measures)
24 secondary outcomes
Perceive Recall Plan Perform Measure (PRPP)
Time frame: 3 months
Zarit Burden Inventory (ZBI)
Time frame: 3 months
Parkinson's Disease Questionnaire 39 (PDQ-39)
Time frame: 3 months
Resource utilization questionnaire
Time frame: 3 months
Objective Caregiving Burden
Time frame: 3 months
Activity Card Sort (ACS)
Time frame: 3 months
The Utrecht Scale for evaluation of Rehabilitation Participation (USER-P)(section III)
Time frame: 3 months
Becks depression Inventory (BDI)
Time frame: 3 months
Hospital Anxiety and Depression Scale (HADS)
Time frame: 3 months
The Utrecht Proactive Coping Competence list (UPCC)
Time frame: 3 months
Fatigue Severity Scale (FSS)
Time frame: 3 months
Canadian Occupational Performance Measure (COPM-satisfaction)
Time frame: 3 months
Quality of life-overall
Time frame: 3 months
Zarit Burden Inventory (ZBI)
Time frame: 6 months
Parkinson's Disease Questionnaire 39 (PDQ-39)
Time frame: 6 months
Objective Caregiving Burden
Time frame: 6 months
Euroqol EQ-5D
Time frame: 6 months
Canadian Occupational Performance Measure (COPM)
Time frame: 6 months
Canadian Occupational Performance Measure (COPM-satisfaction)
Time frame: 6 months
The Utrecht Scale for evaluation of Rehabilitation Participation (USER-P)(section III)
Time frame: 6 months
Becks depression Inventory (BDI)
Time frame: 6 months
Hospital Anxiety and Depression Scale (HADS)
Time frame: 6 months
The Utrecht Proactive Coping Competence list (UPCC)
Time frame: 6 months
Fatigue Severity Scale (FSS)
Time frame: 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Aug 2014.
- Derived from this study: PubMed 25854809Sturkenboom IH, Hendriks JC, Graff MJ, Adang EM, Munneke M, Nijhuis-van der Sanden MW, Bloem BR. Economic evaluation of occupational therapy in Parkinson's disease: A randomized controlled trial. Mov Disord. 2015 Jul;30(8):1059-67. doi: 10.1002/mds.26217. Epub 2015 Apr 8.
- Derived from this study: PubMed 24726066Sturkenboom IH, Graff MJ, Hendriks JC, Veenhuizen Y, Munneke M, Bloem BR, Nijhuis-van der Sanden MW; OTiP study group. Efficacy of occupational therapy for patients with Parkinson's disease: a randomised controlled trial. Lancet Neurol. 2014 Jun;13(6):557-66. doi: 10.1016/S1474-4422(14)70055-9. Epub 2014 Apr 8.
- Derived from this study: PubMed 23374761Sturkenboom IH, Graff MJ, Borm GF, Adang EM, Nijhuis-van der Sanden MW, Bloem BR, Munneke M. Effectiveness of occupational therapy in Parkinson's disease: study protocol for a randomized controlled trial. Trials. 2013 Feb 2;14:34. doi: 10.1186/1745-6215-14-34.
Related trials for Parkinson's Disease
Enrolling by invitationObservational study
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
PARKINSON DISEASE (Disorder), Atypical Parkinsonism
Active, not recruitingPhase 1/2
Clinical Safety and Efficacy of Umbilical Cord Mesenchymal Stromal Cells-derived Exosomes in Patients With Parkinson's Disease
Parkinson Disease (PD)
Active, not recruitingObservational study
Adaptive DBS to Offset STN Dysregulation During Exercise in PD
Parkinson Disease
Not yet recruiting
Compulsive Eating and Brain's Reward System in Different Pathologies
PARKINSON DISEASE (Disorder), Bipolar 1 Disorder
Not yet recruiting
Evaluating the Effect of the Zeen Mobility Device on Clinical Practicality, Safety, and Impact (Via Assessments of Walking, Standing Tolerance, Balance, Endurance, Effort, and Participation in Daily Tasks) in an Outpatient Rehabilitation Setting for Individuals With Mobility Impairments.
Stroke, Parkinson's Disease (PD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Marten Munneke, Phd principal investigator
Radboud University Medical Center
10 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Occupational Therapy in people with Parkinson's Disease, run by Radboud University Medical Center at 10 sites in Netherlands.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 Aug 2014. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 10 sites in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Canadian Occupational Performance Measure (COPM) (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01336127, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Aug 2014.